Skip Navigation



NDT Advance Access published online on October 12, 2004
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh497
© 2004 by European Renal Association - European Dialysis and Transplant Association
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/12/2948    most recent
gfh497v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Anders, H.-J.
Right arrow Articles by Schlöndorff, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anders, H.-J.
Right arrow Articles by Schlöndorff, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial Comment

Current paradigms about chemokines as therapeutic targets

Hans-Joachim Anders 1*, Volker Vielhauer 1, and Detlef Schlöndorff 1

1 Nephrological Center, Medical Policlinic, Ludwig-Maximilians-University Munich, Germany

* To whom correspondence should be addressed. E-mail: hjanders{at}med.uni-muenchen.de.



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.